Page results
-
Smoking is not allowed at any of our hospitals or building.
-
Fears that people with high blood pressure are more at risk from severe Covid-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.
-
A very wide range of patients are seen in the epilepsy and neurology clinics – and advice given to you about how best to prepare for an appointment will vary according to your specific…
-
There are epilepsy specialist nurses working between at the National Hospital for Neurology and Neurosurgery and also the National Hospital for Neurology and Neurosurgery at Chalfont.…
-
Information for patients from overseas visiting UCLH hospitals.
-
How COVID-19 impacts on the cardiovascular conditions
-
This sheet is aimed at those women having urogynaecological operations. You will also be given a booklet on general advice and information about the gynaecology ward.
-
Your specialist multi-disciplinary team (MDT) When you're receiving care for a blood cancer or blood condition at UCLH, you’ll have a team of experts looking after you. This team includes…
-
David understands the meaning of good value. Despite having private health care at his disposal, it was the NHS that he turned to in his hour of need, having become acutely unwell and diagnosed…
-
UCLH is, and always has been, a big part of Suraiya Jones’ life. Diagnosed with Thalassaemia intermedia as a young child, she first came to the hospital aged five. She’s been…
File results
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0576 - Medications within dermatology
-
FOI/2023/0210 - Top five drugs that expired by value
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0670 - Treatment with immunomodulatory medications
-
FOI/2024/0013 - Medications within dermatology and respiratory medicine
-
FOI/2024/0156 - Value licensing - Microsoft software assets
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0721 - New biologic and targeted medications/ treatment within dermatology